WT1 mRNA is overexpressed in various solid cancers, as well as hematologic malignancies, including AML [6], acute lymphocytic leukemia (ALL) [5], chronic myeloid leukemia (CML), and MDS [10–11]. Here, WT1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.